chloroquine has been researched along with alpha-aminopyridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avery, V; Bashyam, S; Bhamidipati, R; Charman, SA; Chibale, K; Douelle, F; Duffy, S; Feng, TS; González Cabrera, D; Hardick, D; Joseph, JT; Katneni, K; Le Manach, C; Mannila, J; Morizzi, J; Nchinda, AT; Shackleford, DM; Waterson, D; White, KL; Wittlin, S; Witty, MJ; Younis, Y; Zabiulla, KM | 1 |
| Chen, M; Chen, T; Feng, J; Gao, L; Guo, H; Liang, Y; Liu, F; Liu, JJ; Ren, H; Shang, D; Shi, P; Thakur, A; Wang, T; Xu, F; Yang, T; Zhang, S | 1 |
| Chibale, K; Egan, TJ; Hunter, R; Joshi, MC; Ndove, J; Nsumiwa, S; Okombo, J; Taylor, D; Wiesner, L | 1 |
| Blanco-Aparicio, C; Hernández-Encinas, E; Llanos, S; Megias, D; Pietrocola, F; Rovira, M; Serrano, M | 1 |
4 other study(ies) available for chloroquine and alpha-aminopyridine
| Article | Year |
|---|---|
3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential.
Topics: Administration, Oral; Aminopyridines; Animals; Antimalarials; Biological Availability; Cell Line; Chloroquine; Cytochrome P-450 Enzyme Inhibitors; Drug Resistance; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Humans; Isoenzymes; Malaria; Mice; Microsomes, Liver; Plasmodium berghei; Plasmodium falciparum; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2012 |
Blockade efficacy of MEK/ERK-dependent autophagy enhances PI3K/Akt inhibitor NVP-BKM120's therapeutic effectiveness in lung cancer cells.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chloroquine; Enzyme Inhibitors; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays | 2016 |
4-Aminoquinoline Antimalarials Containing a Benzylmethylpyridylmethylamine Group Are Active against Drug Resistant Plasmodium falciparum and Exhibit Oral Activity in Mice.
Topics: Administration, Oral; Aminopyridines; Aminoquinolines; Animals; Antimalarials; Cell Membrane Permeability; Chloroquine; CHO Cells; Cricetulus; Drug Evaluation, Preclinical; Drug Resistance, Microbial; ERG1 Potassium Channel; Hemeproteins; Humans; Malaria; Male; Mice, Inbred BALB C; Plasmodium berghei; Plasmodium falciparum; Solubility; Structure-Activity Relationship | 2017 |
Lysosomal trapping of palbociclib and its functional implications.
Topics: Acridine Orange; Aminopyridines; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cellular Senescence; Chloroquine; Cyclin-Dependent Kinase 4; Cytokines; Fluorescent Dyes; Humans; Lysosomal Membrane Proteins; Lysosomes; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines | 2019 |